15 Of Top 20 Biopharma Companies By Revenue Report 5.2% YoY Growth In 2022
The biopharmaceutical industry had an exceptional year in 2022 with notable success for those with COVID-19 vaccines. The majority (15) of the top 20 publicly traded global innovative biopharma companies reported a 5.2% growth in the aggregate revenue to $868.97 billion from 2021 to 2022, reveals GlobalData, a leading data and analytics company. Global Biopharma Companies Report YoY GrowthGlobalData reveals that Novo Nordisk (NYSE:NVO), Pfizer (NYSE:PFE) and Merck & Co (NYSE:MRK) reported YoY revenue growth of 25.7%, 23.4% and 21.7%, respectively, in 2022. Pfizer finished first in the top 20 l...